Key takeaway
Pooling 19 prospective cohort studies of more than 1 million adults aged 18-64 years, more daily sedentary time was linked to higher all-cause mortality, with a cut-off of 7 h/day for self-reported sitting and 9 h/day for device-measured sitting. Few studies used devices, and an observational cut-off is not a proven safe limit.
Study design
Cohort study
Reading basis
Published abstract
Reading focus
Association & confounding
The research question
Sitting a lot is linked to earlier death, but it is unclear how many hours a day is too many. The authors set out to describe the dose-response link between daily sedentary time and all-cause mortality in working-age adults, find the point where health is impaired, and compare self-reported with device-measured sitting.
Who and how
Meta-analysis (meta-regression) of prospective cohort studies reporting effect estimates of daily sedentary time (exposure) on all-cause mortality (outcome) in adults aged 18-64 years. MEDLINE, PubMed, Scopus, Web of Science and Google Scholar were searched until January 2018. Dose-response relationships were examined using random-effects meta-regression models. The analysis included data for more than 1 million participants from 19 studies. The abstract does not report the pooled risk estimates.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1There was a log-linear dose-response association: more time spent in sedentary behaviours was associated with increased mortality risk.
- 2The way sitting was measured moderated the link (p < 0.05).
- 3The cut-off of daily sedentary time was 7 h/day in studies using self-reported sitting and 9 h/day in studies using device-based sitting.
- 4Based on a limited number of device-based studies, the authors suggest it may be appropriate to encourage adults to sit for fewer than 9 h a day for all-cause mortality.
Limits & uncertainty
- 1Cohort studies show association; people who sit more may differ in health, fitness or diet in ways the pooled analysis cannot fully remove.
- 2Only a limited number of studies used device-based measures, so the 9 h/day cut-off is the less certain figure.
- 3Self-reported sitting is prone to recall error, which may explain why the two cut-offs differ.
- 4This reading is based on the abstract only.
What to take from it
Sitting less and breaking up long periods of sitting is a reasonable goal, and the figures of about 7 to 9 hours a day give a rough ceiling rather than a safe zone. This evidence does not say what happens to any one person, and activity levels also matter for health.
Reading your own data
Many watches show inactive time or stand reminders, and sitting estimates from the same device are best compared week to week. Device-based sitting is more reliable than recall, but different devices define sitting differently, so avoid comparing across brands.
How to read this evidence
Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
The appropriate limit to the amount of daily sedentary time (ST) required to minimize mortality is uncertain. This meta-analysis aimed to quantify the dose-response association between daily ST and all-cause mortality and to explore the cut-off point above which health is impaired in adults aged 18-64 years old. We also examined whether there are differences between studies using self-report ST and those with device-based ST.
Methods
Prospective cohort studies providing effect estimates of daily ST (exposure) on all-cause mortality (outcome) were identified via MEDLINE, PubMed, Scopus, Web of Science, and Google Scholar databases until January 2018. Dose-response relationships between daily ST and all-cause mortality were examined using random-effects meta-regression models.
Results
Based on the pooled data for more than 1 million participants from 19 studies, the results showed a log-linear dose-response association between daily ST and all-cause mortality. Overall, more time spent in sedentary behaviors is associated with increased mortality risks. However, the method of measuring ST moderated the association between daily ST and mortality risk (p < 0.05). The cut-off of daily ST in studies with self-report ST was 7 h/day in comparison with 9 h/day for those with device-based ST.
Conclusions
Higher amounts of daily ST are log-linearly associated with increased risk of all-cause mortality in adults. On the basis of a limited number of studies using device-based measures, the findings suggest that it may be appropriate to encourage adults to engage in less sedentary behaviors, with fewer than 9 h a day being relevant for all-cause mortality.
Sources & attribution
A cut-off of daily sedentary time and all-cause mortality in adults: a meta-regression analysis involving more than 1 million participants.
Ku PW, Steptoe A, Liao Y, Hsueh MC, Chen LJ.
BMC medicine · 2018-05-25
DOI: 10.1186/s12916-018-1062-2 ↗PubMed · 29793552 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000
Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.
The Lancet Public Health
Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers
Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.
Nature Medicine
Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)
Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.
The Lancet Public Health
Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality
In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.
BMJ

